中国临床药理学杂志
中國臨床藥理學雜誌
중국림상약이학잡지
THE CHINESE JOURNAL OF CLINICAL PHARMACOLOGY
2015年
11期
942-945
,共4页
张长洪%张志林%张志华%张秀珑%汤建华%刘开杨
張長洪%張誌林%張誌華%張秀瓏%湯建華%劉開楊
장장홍%장지림%장지화%장수롱%탕건화%류개양
川芎嗪%肺癌%缺氧诱导因子1α%碱性成纤维细胞生长因子%血管生成抑制蛋白
川芎嗪%肺癌%缺氧誘導因子1α%堿性成纖維細胞生長因子%血管生成抑製蛋白
천궁진%폐암%결양유도인자1α%감성성섬유세포생장인자%혈관생성억제단백
Tetramethylpyrazine%lung cancer%hypoxia -inducible factor -1α%basic fibroblast growth factor%vasohibin-1
目的:观察川芎嗪联合顺铂对Lewis肺腺癌小鼠瘤组织中的缺氧诱导因子1α( HIF-1α)、碱性成纤维细胞生长因子( b -FGF )、血管生成抑制蛋白( VASH-1)变化并探讨其抗肿瘤机制。方法将48只小鼠模型随机分成4组,对照组、顺铂组(2 mg· kg-1)、川芎嗪组(100 mg· kg-1)和联合组(顺铂组2 mg· kg-1+川芎嗪组100 mg· kg-1),每组12只。给药2周,处死小鼠,称量瘤重,计算抑瘤率;用免疫组化法检测各组HIF-1α、b-FGF、VASH-1的表达。结果与对照组相比,实验组的抑瘤率均明显提高(P<0.05),联合组抑瘤率最高;与对照组相比,3个给药组的HIF-1α、b-FGF、VASH-1表达均明显降低(P<0.05)。 HIF-1α与b-FGF成正相关(P<0.05),b-FGF与VASH-1成正相关(P<0.05),HIF-1α与VASH-1无相关。结论川芎嗪联合顺铂降低HIF-1α的表达,进而降低b-FGF与VASH-1的表达,协同抑制肿瘤生长。
目的:觀察川芎嗪聯閤順鉑對Lewis肺腺癌小鼠瘤組織中的缺氧誘導因子1α( HIF-1α)、堿性成纖維細胞生長因子( b -FGF )、血管生成抑製蛋白( VASH-1)變化併探討其抗腫瘤機製。方法將48隻小鼠模型隨機分成4組,對照組、順鉑組(2 mg· kg-1)、川芎嗪組(100 mg· kg-1)和聯閤組(順鉑組2 mg· kg-1+川芎嗪組100 mg· kg-1),每組12隻。給藥2週,處死小鼠,稱量瘤重,計算抑瘤率;用免疫組化法檢測各組HIF-1α、b-FGF、VASH-1的錶達。結果與對照組相比,實驗組的抑瘤率均明顯提高(P<0.05),聯閤組抑瘤率最高;與對照組相比,3箇給藥組的HIF-1α、b-FGF、VASH-1錶達均明顯降低(P<0.05)。 HIF-1α與b-FGF成正相關(P<0.05),b-FGF與VASH-1成正相關(P<0.05),HIF-1α與VASH-1無相關。結論川芎嗪聯閤順鉑降低HIF-1α的錶達,進而降低b-FGF與VASH-1的錶達,協同抑製腫瘤生長。
목적:관찰천궁진연합순박대Lewis폐선암소서류조직중적결양유도인자1α( HIF-1α)、감성성섬유세포생장인자( b -FGF )、혈관생성억제단백( VASH-1)변화병탐토기항종류궤제。방법장48지소서모형수궤분성4조,대조조、순박조(2 mg· kg-1)、천궁진조(100 mg· kg-1)화연합조(순박조2 mg· kg-1+천궁진조100 mg· kg-1),매조12지。급약2주,처사소서,칭량류중,계산억류솔;용면역조화법검측각조HIF-1α、b-FGF、VASH-1적표체。결과여대조조상비,실험조적억류솔균명현제고(P<0.05),연합조억류솔최고;여대조조상비,3개급약조적HIF-1α、b-FGF、VASH-1표체균명현강저(P<0.05)。 HIF-1α여b-FGF성정상관(P<0.05),b-FGF여VASH-1성정상관(P<0.05),HIF-1α여VASH-1무상관。결론천궁진연합순박강저HIF-1α적표체,진이강저b-FGF여VASH-1적표체,협동억제종류생장。
Objective To observe the effect of Tetramethylpyrazine combined with cisplatin on Lewis lung adenocarcinoma by the change of hypoxia-inducible factor 1 alpha ( HIF -1α) , basic fibroblast growth factorb ( b-FGF) ,vasohibin-1 ( VASH-1 ) in mice tumor tissues and explore the mechanism of anti -tumor.Methods Forty -eight mice were randomly divided into 4 groups, control group, cisplatin group, Tetramethylpyrazine group and combined group, 12 rats in each group, cisplatin at a dose of 2 mg· kg -1 , Tetramethylpyrazine at a dose of 100 mg· kg-1 , combination group( the doses as above).All mice were sac-rificed after treatment for two weeks and these tumors were obtained.The weighed, and the tumor inhibitory was calculated.The expressions of HIF-1α, b -FGF and VASH -1 were determined by immunohisto-chemistry after two weeks administration.Results Compared with the control group, the tumor inhibition rate in experimental groups was signi-ficantly increased ( P<0.05 ) , and was highest in combination group.The expression of HIF -1α, b -FGF and VASH -1 in the cisplatin group, Tetramethylpyrazine group and combined group were decreased obviously compared with control group( P<0.05).And the levels of the expression were the lowest in the combined group and the highest in control group.HIF -1αis positively correlated with b -FGF ( P <0.05 ) , b -FGF is positively correlated with VASH-1 ( P <0.05 ) , HIF-1αis uncorrelated with VASH-1.Conclusion Tetramethylpyrazine combined with cisplatin decreased the expression of HIF-1α, thereby reducing the expression of b-FGF and VASH-1 , inhibiting the tumor growth synergistically.